Earlier this week, Melanoma Research Alliance Chief Science Officer Louise Perkins, PhD, moderated a panel at the 2015 Milken Institute Global Conference. Titled “Breakthrough Medicine: Will Finding a Cure Be Just the Start of Saving Lives?” the panel featured experts across the medical landscape, from industry to practitioners to insurers. With new therapies showing real promise and a national focus on precision medicine, this is an exciting time for science, yet challenges remain.
“The cost to create breakthrough drugs threatens to break the innovators who develop them, as well as the institutes who pick up the tab to pull them forward,” said Dr. Perkins.
Read more about the panel on the Milken Institute’s Currency of Ideas blog or watch the video.